Tying up PGE2 with albumin to relieve immunosuppression in cirrhosis
- 7 May 2014
- journal article
- editorial
- Published by Springer Nature in Nature Medicine
- Vol. 20 (5) , 467-469
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2Nature Medicine, 2014
- Pathological bacterial translocation in liver cirrhosisJournal of Hepatology, 2014
- Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of CirrhosisGastroenterology, 2013
- Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010The Lancet, 2012
- Albumin infusion in patients undergoing large-volume paracentesis: A meta-analysis of randomized trialsHepatology, 2012
- Upregulation of TNF-alpha production signaling pathways in monocytes from patients with advanced cirrhosis: Possible role of Akt and IRAK-MJournal of Hepatology, 2006
- Management of Cirrhosis and AscitesNew England Journal of Medicine, 2004
- Effect of Intravenous Albumin on Renal Impairment and Mortality in Patients with Cirrhosis and Spontaneous Bacterial PeritonitisNew England Journal of Medicine, 1999
- Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: Relationship with the development of renal impairment and mortalityHepatology, 1998
- Tumor necrosis factor α and interleukin 6 plasma levels in infected cirrhotic patientsGastroenterology, 1993